Physician profile
Mitchel J Ibach
NPI 1184934069
$395,178.20
in general payments reported to CMS, 2019-2025
32 companies · $126K in 2025
The $126K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $27K · 2021: $32K · 2022: $52K · 2023: $53K · 2024: $86K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $111K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $89K · Travel and Lodging: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $11K · Honoraria: $1,061 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $110,532.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $89,212.50 |
| Travel and Lodging | $30,366.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,218.50 |
| Food and Beverage | $10,775.93 |
| Honoraria | $1,061.30 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $111,125.13 | 2022-2025 | Miebo, Xiidra, Infuse |
| Glaukos Corporation | $109,195.19 | 2019-2025 | Kxl System, Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Alcon Vision LLC | $48,117.36 | 2019-2025 | Rocklatan, Rhopressa, Tryptyr |
| Dompe US, INC. | $22,038.43 | 2019-2025 | Oxervate |
| Oyster Point Pharma, INC. | $18,826.86 | 2022-2024 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $18,423.27 | 2019-2021 | |
| Sight Sciences, INC. | $13,457.82 | 2019-2025 | Omni Surgical System, Tearcare System |
| Sun Pharmaceutical Industries INC. | $10,051.45 | 2019-2025 | Xelpros, Cequa |
| Alcon Research LLC | $9,776.88 | 2025 | Rhopressa, Rocklatan |
| Thea Pharma INC. | $8,039.39 | 2023-2024 | Iyuzeh |
| Abbvie INC. | $5,612.57 | 2022-2025 | |
| Heru, INC. | $5,000.00 | 2022 | |
| Allergan, INC. | $3,234.08 | 2019-2022 | |
| Reichert, INC. | $2,700.00 | 2025 | |
| Carl Zeiss Meditec, INC. | $2,324.64 | 2019-2025 | Cirrus Hd-Oct, Clarus, Humphrey Field Analyzer (Hfa3) |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $1,500.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $1,157.46 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $1,111.06 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $858.84 | 2024-2025 | Cirrus Hd-Oct, Humphrey Hfa, Clarus |
| Ocular Therapeutix, INC. | $742.02 | 2019-2023 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $585.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $395.85 | 2020-2023 | |
| Mallinckrodt Hospital Products INC. | $257.68 | 2021-2025 | Acthar |
| Biotissue Holdings INC. | $164.94 | 2019-2025 | |
| Shire North American Group INC | $110.84 | 2019 | |
| Harrow Eye, LLC | $106.04 | 2024-2025 | Vevye, Natacyn, Ilevro |
| Amgen INC. | $76.47 | 2024 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $69.52 | 2019-2024 | Healon Duet Pro, Tecnis Iol, Tecnis Iol |
| Horizon Therapeutics Plc | $48.50 | 2022-2023 | Tepezza |
| Rxsight INC | $29.88 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Tearlab Corp | $20.42 | 2022 | |
| The Cameron-Ehlen Group, INC. | $19.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$108.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchel Ibach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.